Analyst Ratings for aTyr Pharma (LIFE) [Buys]

LIFE Rating Summary

LIFE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LIFE
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $8.00 (+142.4%) * Over Last 12-Mos
Rating Score: 2.5 / 10   Percentile Rank: 55%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/1/2015 JPMorgan New Coverage Overweight
(N/A)
42.00
(N/A)
22.89 3.30 -85.58% Details
Like LIFE Ratings? Also take a look at MDCO, OSG, PIP, ORRF

LIFE Ratings News